MAPT and dementia: Briefly, MCI-Stable patients (i.e., those who did not progress to dementia during the study) were significantly younger, had borderline significantly higher MMSE scores, and had significantly higher CSF Aβ1–42 and Aβ42/40 as well as significantly lower CSF Tau and pTau181 compared to the MCI-AD patients (i.e., those who progressed to ADD).